The question of prognosis in breast cancer is a vexed one that tends to be complicated by two different points of view. In one, the surgical approach, the question, What is the prognosis, implies what is the chance that radical surgery will cure? The second is the biological approach. Here the question implies, What is the natural history of this particular tumour? The pathologist must try to answer both forms of the question, in spite of the fact that the surgeon consistently 'ruins' his basic material by removing tumours successfully. In the absence of tumour there can be no prognosis in the biological sense.
However, as Collins (1956) has pointed out, patients who die of breast cancer, regardless of treatment, probably demonstrate the biological potential, or natural history, of their tumour.
Survival time curves from such cases are indeed remarkably similar to those from untreated series in the literature (Daland, 1927; Bloom, 1968) . If this view is accepted the question can be broken down into its two parts: first, Which patients are cured by radical surgery, ie, removal of the breast and axillary nodes, and secondly, Which patients die of breast cancer, ie, have tumours that complete their life history regardless of treatment.
The following paper describes an analysis of this type. ' The staging is that of the International Union against Cancer called the TNM system (T, the tumour; N, the regional lymph nodes; M, distant metastases). The Union recommends fouLr stages from combinations of the several categories of T, N, and M. Received for publication 16 July 1973.
Material and Methods
The necropsy series has already been reported (Harveit, 1971) . It consisted of patients coming to necropsy at this Institute between the years 1963 and 1970. In all cases the cause of death had been recorded as carcinoma of the breast and in all cases material from the primary tumour was also available for classification. In the 87 cases used in the present study sufficient information was available from the pathology reports, the surgical specimens and/or case reports for TNM staging (Harmer, Denoix, and Hamperl, 1970) , ie, two cases from the original series were omitted on these grounds. The surgical series consisted of 147 primary infiltrating breast carcinomas in patients who presented at this Institute between March 1971 and 1972. In all sufficient information was available for TNM staging.
The age of the patients at the time of removal of the primary tumours was recorded in both series, and the age at death in the necropsy series.
One section from each primary tumour, formalinfixed, paraffin-embedded, and stained with haematoxylin and eosin was examined. In the surgical series the histological classification was recorded twice by one of us (H.) at an interval of five weeks, the order of the specimens being unknown. The method has been described in detail (Hartveit, 1971 The overrepresentation may be due to selection of younger patients dying of cancer for treatment in hospital, while the underrepresentation could reflect the more frequent use of a previously established diagnosis in death certification in older women when necropsy has not been carried out (see Prutting, 1972) .
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Discussion
The assessment of different methods of treatment of infiltrating breast cancer has long been hampered by the scatter in survival time that is to be expected. This is due to the great differences in life history that occur from tumour to tumour (Bloom, 1968) . For this reason five-year survival rates underestimate the mortality. Ten years at least are required before an approximately reliable picture emerges (Bloom and Richardson, 1957 The finding that type I tumours predominate in the biopsy series, if confirmed from other centres1, will make it possible to assess treatment on these patients alone. If such patients die of their tumours the necropsy series indicates that they do so within a few years, irrespective of TNM stage, with the exception of stage I which was not found in the necropsy series. Thus five-year survival rates can be expected to give meaningful information about these type I tumours.
Differentiation as to histological type was numerically possible with type I. No significant differences in survival time related to histological type were demonstrated in the necropsy series within the different TNM stages. However, not all patients with type I tumours die of breast cancer; in other words the possibility of surgical cure should not be forgotten.
On comparison with the necropsy series it appeared that there was a possible overrepresentation of type 1 duct carcinomas in the biopsy series. Further analysis showed that this was due mainly to stage II tumours, which accounted for 17% of the surgical material, while none were found in the necropsy series. Due mainly to these duct carcinomas, stage II tumours as a whole were better represented in the surgical material than stage III, while the opposite was true for the necropsy series. This suggests that the possibility of cure, as opposed to a prolonged survival time, may be better in type I stage II duct carcinomas than in the other histological types.
In contrast stage II and III medullary type I tumours were overrepresented in the necropsy series, suggesting that the possibility of cure may be lower here, though the number of cases involved is small too. In addition the difference in survival time between stages II and III was not significant in contrast to scirrhous and adenocarcinomas in which the survival time was significantly less in stage III than in stage II.
Although only cases in which a consistent histological diagnosis was reached were used in these 'See addendum comparisons it should be remembered that such classification is subjective and carries different degrees of error within the different histological types, for example, 86 % agreement on two readings for duct compared to 63 % for scirrhous carcinoma in the present series. Schi0dt (1966) concluded that histological classification is of no prognostic value in other than colloid and medullary carcinoma (10% of his material.) His use of the method, however, implies that such classification was regarded as consistent enough to justify the conclusion. It is well known that most breast carcinomas will show variation in histological pattern within the same slide. Preliminary studies on a group of tumours indicate that this variation may not increase from block to block in the same tumour.
The TNM staging showed up differences in survival time within cytological type I and in the necropsy series as a whole, but not in types II and III separately. Significant differences in survival time related to stage were also found in type I scirrhous and adenocarcinomas but not in medullary carcinomas. It is thus possible that to obtain the greatest use of TNM staging for the comparison of treatment results in tumours of different stages the basic material should be confined to type I tumours of similar histological type. This work was carried out with the technical help of Miss S. Heieren financed bythe Norwegian Cancer Society.
